Robert Ramirez, DO, FACP
Medical Oncologist
Ochsner Health Center – Kenner
Dr. Robert Ramirez is the featured guest for CCF’s Luncheon with the Experts on Thursday, October 8, 2020. Dr. Ramirez has clinical and research interests in neuroendocrine tumors of the lung including DIPNECH, typical and atypical carcinoids, as well as lung cancer, specifically non-small cell and small cell cancers. Dr. Ramirez splits his clinical and research duties between the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic. He is active in clinical trial design as well as teaching.
He is board certified in medical oncology and internal medicine. Dr. Ramirez is a Fellow of the American College of Physicians (FACP) and a member of American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS).
Resources:
- Neuroendocrine Tumor Clinic (NOLANETS) at Ochsner Medical Center: https://www.ochsner.org/services/neuroendocrine-tumor-program
- North American Neuroendocrine Tumor Society (NANETS): https://nanets.net
Selected Articles:
- Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines, https://www.carcinoid.org/wp-content/uploads/2020/10/Commnet-NANETS-Lung-Guidelines-2020.pdf
- Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids, https://www.clinical-lung-cancer.com/article/S1525-7304(19)30057-9/fulltext
- A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID-19 Pandemic, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356714/
- The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912368/
- Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693730/
- Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830950/
- Prognostic Factors in Typical and Atypical Pulmonary Carcinoids, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718446/
- Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017154/
Social Media:
- NOLANETS on Facebook: https://www.facebook.com/nolanets
- Ochsner Health on Facebook: https://www.facebook.com/OchsnerHealth
- Ochsner Health on Twitter: https://twitter.com/OchsnerHealth
